SALIM VIRANI to Anti-Arrhythmia Agents
This is a "connection" page, showing publications SALIM VIRANI has written about Anti-Arrhythmia Agents.
Connection Strength
0.152
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project. Am J Cardiol. 2017 02 15; 119(4):579-584.
Score: 0.121
-
Factors associated with rhythm control treatment decisions in patients with atrial fibrillation-Insights from the NCDR PINNACLE registry. Am Heart J. 2017 May; 187:88-97.
Score: 0.031